S1PR1 and neoplasm: In addition, S1P interacts with its receptor S1PR1-5, coordinating a multifaceted regulatory network and affecting the dynamic balance of cytotoxic T cells, Tregs, Th17 cells, and NK cells (89), thus affecting tumor progression and the efficacy of immunotherapy by regulating the tumor immune microenvironment.